Nanoemulsions - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB504243570

Publication Date:

April 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.
The global market for Nanoemulsions was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
In USA, EU, Japan, China, India and Southeast Asia, Nanoemulsions key players include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, etc.
USA is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent.
In terms of application, the largest application is Pharmaceutical Industrial, with a share over 45%, followed by Cosmetic Industrial, Food Industrial, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nanoemulsions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Nanoemulsions by region & country, by Type, and by Application.
The Nanoemulsions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanoemulsions.
麻豆原创 Segmentation
By Company
Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen
Segment by Type:
Steroids
Anesthetics
NSAIDs
Immunosuppressant
Antiretroviral
Antimicrobials
Vasodilators
Others
Segment by Application
Pharmaceutical Industrial
Cosmetic Industrial
Food Industrial
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Nanoemulsions manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Nanoemulsions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Nanoemulsions in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Nanoemulsions Product Introduction
1.2 Global Nanoemulsions 麻豆原创 Size Forecast
1.3 Nanoemulsions 麻豆原创 Trends & Drivers
1.3.1 Nanoemulsions Industry Trends
1.3.2 Nanoemulsions 麻豆原创 Drivers & Opportunity
1.3.3 Nanoemulsions 麻豆原创 Challenges
1.3.4 Nanoemulsions 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Nanoemulsions Players Revenue Ranking (2023)
2.2 Global Nanoemulsions Revenue by Company (2019-2024)
2.3 Key Companies Nanoemulsions Manufacturing Base Distribution and Headquarters
2.4 Key Companies Nanoemulsions Product Offered
2.5 Key Companies Time to Begin Mass Production of Nanoemulsions
2.6 Nanoemulsions 麻豆原创 Competitive Analysis
2.6.1 Nanoemulsions 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Nanoemulsions Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoemulsions as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Steroids
3.1.2 Anesthetics
3.1.3 NSAIDs
3.1.4 Immunosuppressant
3.1.5 Antiretroviral
3.1.6 Antimicrobials
3.1.7 Vasodilators
3.1.8 Others
3.2 Global Nanoemulsions Sales Value by Type
3.2.1 Global Nanoemulsions Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Nanoemulsions Sales Value, by Type (2019-2030)
3.2.3 Global Nanoemulsions Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Industrial
4.1.2 Cosmetic Industrial
4.1.3 Food Industrial
4.1.4 Others
4.2 Global Nanoemulsions Sales Value by Application
4.2.1 Global Nanoemulsions Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Nanoemulsions Sales Value, by Application (2019-2030)
4.2.3 Global Nanoemulsions Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Nanoemulsions Sales Value by Region
5.1.1 Global Nanoemulsions Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Nanoemulsions Sales Value by Region (2019-2024)
5.1.3 Global Nanoemulsions Sales Value by Region (2025-2030)
5.1.4 Global Nanoemulsions Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Nanoemulsions Sales Value, 2019-2030
5.2.2 North America Nanoemulsions Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Nanoemulsions Sales Value, 2019-2030
5.3.2 Europe Nanoemulsions Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Nanoemulsions Sales Value, 2019-2030
5.4.2 Asia Pacific Nanoemulsions Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Nanoemulsions Sales Value, 2019-2030
5.5.2 South America Nanoemulsions Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Nanoemulsions Sales Value, 2019-2030
5.6.2 Middle East & Africa Nanoemulsions Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Nanoemulsions Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Nanoemulsions Sales Value
6.3 United States
6.3.1 United States Nanoemulsions Sales Value, 2019-2030
6.3.2 United States Nanoemulsions Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Nanoemulsions Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Nanoemulsions Sales Value, 2019-2030
6.4.2 Europe Nanoemulsions Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Nanoemulsions Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Nanoemulsions Sales Value, 2019-2030
6.5.2 China Nanoemulsions Sales Value by Type (%), 2023 VS 2030
6.5.3 China Nanoemulsions Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Nanoemulsions Sales Value, 2019-2030
6.6.2 Japan Nanoemulsions Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Nanoemulsions Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Nanoemulsions Sales Value, 2019-2030
6.7.2 South Korea Nanoemulsions Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Nanoemulsions Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Nanoemulsions Sales Value, 2019-2030
6.8.2 Southeast Asia Nanoemulsions Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Nanoemulsions Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Nanoemulsions Sales Value, 2019-2030
6.9.2 India Nanoemulsions Sales Value by Type (%), 2023 VS 2030
6.9.3 India Nanoemulsions Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Allergan plc
7.1.1 Allergan plc Profile
7.1.2 Allergan plc Main Business
7.1.3 Allergan plc Nanoemulsions Products, Services and Solutions
7.1.4 Allergan plc Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.1.5 Allergan plc Recent Developments
7.2 AbbVie Inc.
7.2.1 AbbVie Inc. Profile
7.2.2 AbbVie Inc. Main Business
7.2.3 AbbVie Inc. Nanoemulsions Products, Services and Solutions
7.2.4 AbbVie Inc. Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.2.5 AbbVie Inc. Recent Developments
7.3 AstraZeneca Inc.
7.3.1 AstraZeneca Inc. Profile
7.3.2 AstraZeneca Inc. Main Business
7.3.3 AstraZeneca Inc. Nanoemulsions Products, Services and Solutions
7.3.4 AstraZeneca Inc. Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.3.5 Fresenius Kabi AG Recent Developments
7.4 Fresenius Kabi AG
7.4.1 Fresenius Kabi AG Profile
7.4.2 Fresenius Kabi AG Main Business
7.4.3 Fresenius Kabi AG Nanoemulsions Products, Services and Solutions
7.4.4 Fresenius Kabi AG Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.4.5 Fresenius Kabi AG Recent Developments
7.5 Kaken Pharmaceutical
7.5.1 Kaken Pharmaceutical Profile
7.5.2 Kaken Pharmaceutical Main Business
7.5.3 Kaken Pharmaceutical Nanoemulsions Products, Services and Solutions
7.5.4 Kaken Pharmaceutical Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.5.5 Kaken Pharmaceutical Recent Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Profile
7.6.2 GlaxoSmithKline Main Business
7.6.3 GlaxoSmithKline Nanoemulsions Products, Services and Solutions
7.6.4 GlaxoSmithKline Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.6.5 GlaxoSmithKline Recent Developments
7.7 Novartis AG
7.7.1 Novartis AG Profile
7.7.2 Novartis AG Main Business
7.7.3 Novartis AG Nanoemulsions Products, Services and Solutions
7.7.4 Novartis AG Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.7.5 Novartis AG Recent Developments
7.8 Sanofi
7.8.1 Sanofi Profile
7.8.2 Sanofi Main Business
7.8.3 Sanofi Nanoemulsions Products, Services and Solutions
7.8.4 Sanofi Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.8.5 Sanofi Recent Developments
7.9 B. Braun Melsungen
7.9.1 B. Braun Melsungen Profile
7.9.2 B. Braun Melsungen Main Business
7.9.3 B. Braun Melsungen Nanoemulsions Products, Services and Solutions
7.9.4 B. Braun Melsungen Nanoemulsions Revenue (US$ Million) & (2019-2024)
7.9.5 B. Braun Melsungen Recent Developments
8 Industry Chain Analysis
8.1 Nanoemulsions Industrial Chain
8.2 Nanoemulsions Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Nanoemulsions Sales Model
8.5.2 Sales Channel
8.5.3 Nanoemulsions Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.